[Federal Register Volume 68, Number 94 (Thursday, May 15, 2003)]
[Notices]
[Page 26355]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-12151]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances Notice of Registration

    By Notice dated January 6, 2003, and published in the Federal 
Register on January 28, 2003, (68 FR 4233), Bristol-Myers Squibb Pharma 
Company, 1000 Stewart Avenue, Garden City, New York 11530, made 
application by renewal to the Drug Enforcement Administration to be 
registered as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Oxycodone (9143)...........................  II
Hydrocodone (9193).........................  II
Oxymorphone (9652).........................  II
------------------------------------------------------------------------

    The firm plans to manufacture the controlled substances to make 
finished products.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Bristol-Myers Squibb Pharma Company 
to manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated Bristol-Myers Squibb 
Pharma Company to ensure that the company's registration is consistent 
with the public interest. The investigation included inspection and 
testing of the company's physical security systems, verification of the 
company's compliance with state and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 
Sec.  823 and 28 CFR Sec. Sec.  0.100 and 0.104, the Deputy Assistant 
Administrator, Office of Diversion Control, hereby orders that the 
application submitted by the above firm for registration as a bulk 
manufacturer of the basic classes of controlled substances listed above 
is granted.

    Dated: April 16, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-12151 Filed 5-14-03; 8:45 am]
BILLING CODE 4410-09-M